New drug combo tested to control blood cancer in First-Time patients

NCT ID NCT04447768

Summary

This study is testing how well a combination of two drugs, venetoclax and obinutuzumab, works for people with chronic lymphocytic leukemia (CLL) who have not yet received any treatment. It aims to see if this combination can control the cancer and delay its progression. The trial will enroll about 100 adults who are otherwise relatively fit and healthy aside from their CLL diagnosis.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Memorial Sloan Kettering Basking Ridge (All protocol activities)

    Basking Ridge, New Jersey, 07920, United States

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Commack (All protocol activities)

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth (All protocol activities)

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Nassau (All protocol activities)

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering Westchester (All protocol activities)

    Harrison, New York, 10604, United States

  • Stanford University Medical Center (Data collection only)

    Stanford, California, 94305-5408, United States

  • University of North Carolina

    Chapel Hill, North Carolina, 27514, United States

Conditions

Explore the condition pages connected to this study.